Akèy › Kansè pwostat › Washington › Tacoma
Etid klinik pou Kansè pwostat nan Tacoma, WA
11 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Tacoma (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Providence Regional Cancer System-Lacey, Lacey · 23 mi lwen
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Ap rekriteFaz 3
- Northwest Medical Specialties, PLLC, Tacoma
- Northwest Medical Specialties, PLLC, Gig Harbor · 8 mi lwen
- Northwest Medical Specialties, PLLC, Puyallup · 8 mi lwen
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Ap rekriteFaz 3
- Northwest Medical Specialties, PLLC, Tacoma
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Ap rekriteFaz 3
- Northwest Medical Specialties, Tacoma
The Vanguard Study: Testing a New Way to Screen for Cancer
Ap rekriteVolontè an sante akeyi
- Madigan Army Medical Center, Tacoma
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Ap rekriteFaz 3
- Research Site, Tacoma
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Ap rekriteFaz 3
- Providence Regional Cancer System-Lacey, Lacey · 23 mi lwen
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ap rekriteFaz 2
- Northwest Medical Specialties, PLLC - Tacoma, Tacoma
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Ap rekriteFaz 3
- Providence Regional Cancer System-Lacey, Lacey · 23 mi lwen
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Ap rekriteFaz 1
- Northwest Medical Specialties, Tacoma
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Ap rekriteFaz 2
- Providence Regional Cancer System-Yelm, Yelm · 23 mi lwen
- Providence Regional Cancer System-Lacey, Lacey · 23 mi lwen
Etid Kansè pwostat nan lòt vil
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Baltimore, MD43 etid
- Nashville, TN42 etid
- Seattle, WA42 etid
- Washington, DC38 etid
Lòt etid nan Tacoma
- Kansè Poumon ki pa ti selil20 etid
- Kansè nan tete18 etid
- Kolit Ulseratif15 etid
- Myelom Miltip13 etid
- Maladi Crohn11 etid
- Kansè Metastatik9 etid
- Kansè kolorektal9 etid
- Melanom7 etid
- Kansè ovè7 etid
- Kansè (tout kalite)6 etid
- Kansè pankreyas6 etid
- Obèsite6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.